Exco InTouch named ‘Microsoft Managed Partner’ within life sciences

Wednesday, June 27, 2012 02:51 PM

Exco InTouch, a provider of mobile patient engagement, data collection and communication solutions for the pharmaceutical and healthcare sectors, has been named a Microsoft Managed Partner.

Exco has been recognized by Microsoft’s Life Science team for the company’s expertise in managing patients in regulatory and late phase clinical trials, as well as in the emerging mHealth space for marketed drugs.

Exco InTouch was selected based on a number of criteria, including the company’s established track record of providing unique solutions using cutting-edge technologies, in addition to revenue potential and growth. Exco InTouch is a global provider of regulatory compliant, simple and non-intrusive mobile patient communication solutions for clinical, late phase and mHealth studies. This enables sponsors and CROs to find and retain the right patients through engaging interactions and improved patient experience. The Managed Partner program will provide Exco InTouch with valuable resources to accelerate the adoption of its solutions in the life sciences market.

“Exco InTouch is delighted to be included in the elite group of Microsoft Managed Partners. The early access we will receive to emerging Microsoft technologies, information, tools and support will enable us to develop the most advanced patient engagement solutions to date and our customers can look forward to experiencing these benefits as our partnership with Microsoft continues,” said Tim Davis, CEO of Exco InTouch.

“As the life sciences industry continues to adapt to increased regulatory standards and a higher volume of patients, new technology solutions have the potential to revolutionize the way we manage these processes,” said Andrea McGonigle, managing director, Microsoft Life Sciences. “Exco InTouch is an example of a partner that can help companies deliver reliable data throughout their clinical and late phase studies in an accessible and user friendly way.”

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

July 28

WCG acquires Alliance Biosciences to expand its biosafety oversight capabilities, ensure compliance

Facilitated review meetings for protocol design catching on, decreasing amendments, complexity

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

July

IRB market consolidating rapidly
Private equity driving a new commercial ethical review landscape

Lessons learned from medical device trials
Smaller, faster, more flexible trials hold important insights for pharmaceutical innovation

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

June

CRO market poised for growth and consolidation
Sponsors expanding pipelines, shrinking infrastructure fuel strategic outsourcing

Strategies for success evolving in phase I space
Sites see increasing complexity, more patients, greater focus on efficacy

Already a subscriber?
Log in to your digital subscription.

Purchase the June issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs